HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minu K Srivastava Selected Research

Cancer Vaccines

3/2008The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minu K Srivastava Research Topics

Disease

19Neoplasms (Cancer)
07/2021 - 05/2007
8Lung Neoplasms (Lung Cancer)
04/2015 - 10/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 12/2010
2Neoplasm Metastasis (Metastasis)
05/2016 - 11/2015
2Uveal melanoma
01/2010 - 05/2007
2Melanoma (Melanoma, Malignant)
01/2010 - 05/2007
1Lymphoma (Lymphomas)
01/2017
1Carcinogenesis
11/2013
1Neuroinflammatory Diseases
05/2012
1Alzheimer Disease (Alzheimer's Disease)
05/2012
1Large Cell Carcinoma
12/2010
1Carcinoma (Carcinomatosis)
03/2008

Drug/Important Bio-Agent (IBA)

5Interleukin-10 (Interleukin 10)IBA
04/2015 - 05/2011
5VaccinesIBA
12/2010 - 05/2007
3LigandsIBA
01/2013 - 06/2011
3CytokinesIBA
10/2012 - 05/2011
2TetraspaninsIBA
05/2016 - 11/2015
2Interleukin-12 (IL 12)IBA
04/2015 - 06/2011
2ChemokinesIBA
04/2015 - 10/2012
25'-N-methylcarboxamideadenosineIBA
04/2015 - 01/2012
2Chemokine CCL21IBA
01/2013 - 05/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 01/2012
2Histocompatibility Antigens Class IIIBA
01/2010 - 05/2007
2Peptides (Polypeptides)IBA
01/2010 - 03/2008
1sotigalimabIBA
07/2021
1AntibodiesIBA
07/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
11/2015
1Caspase 3 (Caspase-3)IBA
04/2015
1Interleukin-27 (Interleukin 27)IBA
11/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2013
1Cadherins (E-Cadherin)IBA
01/2013
1Histones (Histone)IBA
01/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2012
13,6'-dithiothalidomideIBA
05/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012
1Thalidomide (Thalomid)FDA Link
05/2012
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2012
1Interleukin-6 (Interleukin 6)IBA
03/2012
1Dinoprostone (PGE2)FDA Link
03/2012
1PerforinIBA
01/2012
1Granzymes (Granzyme)IBA
01/2012
1Protein Subunit VaccinesIBA
08/2011
1B7-H1 AntigenIBA
06/2011
1ArginaseIBA
06/2011
1NanocapsulesIBA
05/2011
1HLA-DR Antigens (HLA-DR)IBA
12/2010
1HLA-A Antigens (HLA-A)IBA
01/2010
1invariant chain (Ii-Key)IBA
03/2008
1Cancer VaccinesIBA
03/2008
1AntigensIBA
05/2007

Therapy/Procedure

4Therapeutics
04/2015 - 08/2011
3Immunotherapy
07/2021 - 05/2007
2Drug Therapy (Chemotherapy)
01/2013 - 08/2011
2Radiotherapy
01/2013 - 08/2011
1Immunomodulation
11/2015
1Aftercare (After-Treatment)
05/2012